To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").

Every bill carries a core record (title, sponsor, latest action) that Concord fetches up front. The detailed sections — cosponsors, action history, subjects, titles, and summaries — live behind separate Congress.gov endpoints, so they're fetched on demand rather than for all 50,000+ bills at once. Until a bill has been enriched, those sections stay empty.